Results 171 to 180 of about 24,815 (217)
Video-Assisted Thoracoscopic Surgery Versus Tube Thoracostomy with Fibrinolytics for Treatment of Empyema in Children: A Meta-Analysis of Randomized Controlled Studies. [PDF]
Children (Basel)Miscia ME +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Progress in Cardiovascular Diseases, 1979
W ITHOUT question, degenerative vascular disease remains the major cause of death and morbidity in the Western world. In the United Kingdom, cardiovascular disease is responsible for about 50% of all deaths in men aged 45-54 yr, and this must be compared with only 25% of deaths in this age group resulting from cancers.’ Although little direct proof ...
J F, Davidson, I D, Walker
openaire +2 more sources
W ITHOUT question, degenerative vascular disease remains the major cause of death and morbidity in the Western world. In the United Kingdom, cardiovascular disease is responsible for about 50% of all deaths in men aged 45-54 yr, and this must be compared with only 25% of deaths in this age group resulting from cancers.’ Although little direct proof ...
J F, Davidson, I D, Walker
openaire +2 more sources
[Enzymatic fibrinolytic agents].
Annales de l'anesthesiologie francaise, 1979Urokinase (UK) and streptokinase (SK) transform plasminogen into plasmin by rupture of a ARG-VAL bond and the liberation of a peptide with a molecular weight of 6000 to 8000. Urokinase is a physiological activator with a direct action. By contrast, streptokinase is an enzyme of bacterial origin and two hypotheses may be advanced to explain its ...
M, Jamet, C, Granthil, G, Levy
openaire +2 more sources
Development of New Fibrinolytic Agents
Current Pharmaceutical Design, 2006Since the activation of coagulation system and platelets triggers the thrombosis, the agents possessing anticoagulation or anti-platelet function have been used for the antithrombotic procession actions. However, in the physiological condition, the fibrinolytic system serves as antithrombotic, which removes the thrombus from the circulation.
Shigeru, Ueshima, Osamu, Matsuo
openaire +2 more sources
Tenecteplase: A promising new fibrinolytic agent
Dimensions of Critical Care Nursing, 2001Acute coronary syndrome can mean anything from unstable angina to acute myocardial infarction (MI) with ST-segment elevation. Tenecteplase, a new fibrinolytic agent used to treat ST-segment elevation acute MI, has some advantages over other fibrinolytic agents. This article describes tenecteplase's actions, indications, contraindications, and use.
M J, De Jong, W, Sabadie-Garretson
openaire +2 more sources
2006
The fibrinolytic system plays a vital role in maintaining vital organ homeostasis. Fibrinolysis, defined as the dissolution of fibrin (the major scaffold for intravascular thrombus), is the process that regulates thrombus growth after hemostasis has been achieved, thus preserving tissue perfusion.
Richard C. Becker, Frederick A. Spencer
openaire +1 more source
The fibrinolytic system plays a vital role in maintaining vital organ homeostasis. Fibrinolysis, defined as the dissolution of fibrin (the major scaffold for intravascular thrombus), is the process that regulates thrombus growth after hemostasis has been achieved, thus preserving tissue perfusion.
Richard C. Becker, Frederick A. Spencer
openaire +1 more source
Fibrinolytic agents for peripheral arterial occlusion
Cochrane Database of Systematic Reviews, 2010Peripheral arterial thrombolysis is used in the management of peripheral arterial ischaemia. Streptokinase was originally used but safety concerns led to a search for other agents. Urokinase and recombinant tissue plasminogen activator (rt-PA) have increasingly become established as first line agents for peripheral arterial thrombolysis.
Iain, Robertson +2 more
openaire +3 more sources